Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01254019
Show Display Options
Rank Status Study
1 Completed A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
Condition: Muscular Dystrophies
Intervention: Drug: GSK2402968 6mg/kg/week

Indicates status has not been verified in more than two years